Trials / Active Not Recruiting
Active Not RecruitingNCT04611997
IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- Sponsor
- Fujian Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Patients with locally advanced gastric adenocarcinoma (cT2-4a N-/+ M0) were selected as study subjects to investigate the safety, efficacy, and feasibility of ICG near-infrared imaging tracing in guiding laparoscopic D2 lymph node dissection for gastric cancer after neoadjuvant chemotherapy by comparing injection ICG group and non-injection ICG group
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Indocyanine Green | Indocyanine Green Tracer Using in Laparoscopic Gastrectomy with Lymph Node Dissection for Locally Advanced Gastric Cancer After Neoadjuvant |
Timeline
- Start date
- 2020-11-16
- Primary completion
- 2026-10-01
- Completion
- 2026-10-01
- First posted
- 2020-11-02
- Last updated
- 2023-09-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04611997. Inclusion in this directory is not an endorsement.